ArticleCureus2025
Delayed Post-percutaneous Nephrolithotomy Hemorrhage Managed With Superselective Renal Artery Embolization: A Nephron-Sparing Therapeutic Approach.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Persistent hematuria after PCNL: a rare case report of renal pseudoaneurysm managed with endovascular coil embolization in Indonesia.International journal of surgery case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous nephrolithotomy (PCNL) is the preferred treatment for large renal stones, though delayed arterial bleeding is a rare but serious complication. A 59-year-old male, previously discharged post-PCNL, presented on postoperative day 10 with gross hematuria and clot retention. CT angiography confirmed an interpolar segmental artery pseudoaneurysm. Superselective renal artery embolization (SSAE) with n-butyl cyanoacrylate achieved hemostasis without transfusion. Renal function was preserved, and the patient recovered uneventfully. The patient was reviewed after two weeks for follow-up after SSAE. This case illustrates the value of prompt vascular imaging in delayed post-PCNL bleeding and highlights the role of superselective renal artery angioembolization as a safe, effective, nephron-sparing intervention in modern endourological practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.